| |
|
|
|
Clovis Oncology Inc  
|
|
4.6616 0.052 (0.01%) |
09-17 10:00 |
|
Open: |
4.61 |
Pre close: |
4.61 |
Target:
|
5.84 
|
|
High: |
4.69 |
Low: |
4.59 |
Resistance:
|
5.00
5.84
|
|
Volume: |
371,569 |
Market Cap: |
552M |
Support:
|
4.42
4.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.41
|
MACD |
MACD(12,26):
|
-0.10 |
|
MA(20): |
4.54 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
5.24  |
Stochastic Oscillator |
%K(14,3):
|
28.14 |
|
MA(250): |
5.65 |
%D(3): |
19.29 |
|
Average Volume(K) |
3-Month: |
11808983
|
52-Week |
High:
|
11.10 |
|
10-Days: |
8180083 |
Low: |
4.06 |
|
RSI |
RSI(14):
|
49.58 |
Change(%): |
-33.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.636 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
104.56 |
|
EPS Est. Current Year |
-7.580 |
Return on Assets (ttm) |
-30.2 |
Shares Float (M) |
102.67 |
|
EPS Est. Next Year |
-2.460 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.84 |
|
EPS Est. Next Quarter |
-1.150 |
Qtrly Rev. Growth |
-10.6 |
% Held by Institutions |
50.42 |
|
Forward EPS |
-7.430 |
Gross Profit (p.s.) |
1.228 |
Shares Short (K) |
30810 |
|
Book Value (p.s.) |
-2.110 |
EBITDA (p.s.) |
-2.581 |
P/E |
-1.27 |
|
Sales Per Share |
1.530 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.18 |
|
Profit Margin |
-210.08 |
Operating Cash Flow
(M) |
-232.12 |
P/S |
3.01 |
|
Operating Margin |
-173.85 |
Levered Free Cash Flow
(M) |
-147.60 |
P/CF |
-2.08 |
|
|
|
|
|
|
